Q-omics provides the consensus-scored YWHAEP7 profile across patient tissues and cancer cell-line models. YWHAEP7 expression is associated with patient survival in 17 of 34 cancer types, with the highest sampling consensus in STAD. Among the 18 cancer types available for tumor–normal comparison, YWHAEP7 is differentially expressed in 12, with the highest sampling consensus in THCA. Additionally, YWHAEP7 RNA expression shows 9,631 significant gene co-expression associations, with the highest sampling consensus in KIRP. Together, these results highlight STAD, THCA, and KIRP as cancer lineages where YWHAEP7 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for YWHAEP7 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes YWHAEP7 survival associations across molecular data types. YWHAEP7 RNA expression shows survival associations in the most cancer types (17). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible YWHAEP7 RNA expression–survival associations across cancer types. High YWHAEP7 expression shows unfavorable associations in STAD, LGG, MESO, ACC and UVM, but favorable associations in KIRP. The STAD Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .003). Together, the overview and detailed table identify STAD as the clearest survival context for YWHAEP7 RNA expression.
This table summarizes YWHAEP7 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 12. The strongest signals are observed in THCA for RNA.
This table ranks reproducible tumor–normal expression differences for YWHAEP7. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. YWHAEP7 shows lower tumor expression in KIRC, KICH and COAD and higher tumor expression in THCA, LUAD and BLCA. The THCA box plot shows higher YWHAEP7 RNA expression in tumor versus normal tissue (log2 FC = +0.857, t-test p < 0.001).
This table shows molecular features associated with YWHAEP7 in patient tissues and cancer cell lines. In patient samples, YWHAEP7 shows the broadest associations at the RNA and protein expression levels, with KIRP recurring as the lineage with the largest associated feature set.
